About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2012 (2012), Article ID 963417, 8 pages
http://dx.doi.org/10.1155/2012/963417
Review Article

Postoperative Radiotherapy after Radical Prostatectomy: Indications and Open Questions

1Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, 3010 Bern, Switzerland
2Department of Radiation Oncology, Kantonsspital Graubünden, 7000 Chur, Switzerland
3Department of Radiation Oncology, University Hospital Basel, 4031 Basel, Switzerland

Received 15 July 2011; Revised 14 December 2011; Accepted 15 December 2011

Academic Editor: Jay P. Ciezki

Copyright © 2012 Pirus Ghadjar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Han, A. W. Partin, M. Zahurak, S. Piantadosi, J. I. Epstein, and P. C. Walsh, “Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer,” Journal of Urology, vol. 169, no. 2, pp. 517–523, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. F. Ward and J. W. Moul, “Rising prostate-specific antigen after primary prostate cancer therapy,” Nature Clinical Practice Urology, vol. 2, no. 4, pp. 174–182, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. L. Amling, M. L. Blute, E. J. Bergstralh, T. M. Seay, J. Slezak, and H. Zincke, “Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years,” Journal of Urology, vol. 164, no. 1, pp. 101–105, 2000. View at Scopus
  4. P. A. Kupelian, J. Katcher, H. S. Levin, and E. A. Klein, “Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy,” International Journal of Radiation Oncology Biology Physics, vol. 37, no. 5, pp. 1043–1052, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Pinto, T. Prayer-Galetti, M. Gardiman et al., “Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer,” Urologia Internationalis, vol. 76, no. 3, pp. 202–208, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. R. Pound, A. W. Partin, M. A. Eisenberger, D. W. Chan, J. D. Pearson, and P. C. Walsh, “Natural history of progression after PSA elevation following radical prostatectomy,” Journal of the American Medical Association, vol. 281, no. 17, pp. 1591–1597, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. S. F. Slovin, A. S. Wilton, G. Heller, and H. I. Scher, “Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy,” Clinical Cancer Research, vol. 11, no. 24, pp. 8669–8673, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. L. H. Klotz, “PSA recurrence: definitions, PSA kinetics, and identifying patients at risk,” The Canadian Journal of Urology, vol. 13, supplement 2, pp. 43–47, 2006. View at Scopus
  9. A. J. Stephenson, P. T. Scardino, M. W. Kattan et al., “Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy,” Journal of Clinical Oncology, vol. 25, no. 15, pp. 2035–2041, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Bolla, H. Van Poppel, L. Collette et al., “Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911),” The Lancet, vol. 366, no. 9485, pp. 572–578, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. I. M. Thompson Jr., C. M. Tangen, J. Paradelo et al., “Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial,” Journal of the American Medical Association, vol. 296, no. 19, pp. 2329–2335, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. T. Wiegel, D. Bottke, U. Steiner et al., “Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95,” Journal of Clinical Oncology, vol. 27, no. 18, pp. 2924–2930, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. I. M. Thompson, C. M. Tangen, J. Paradelo et al., “Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial,” Journal of Urology, vol. 181, no. 3, pp. 956–962, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. T. H. Van Der Kwast, M. Bolla, H. Van Poppel et al., “Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911,” Journal of Clinical Oncology, vol. 25, no. 27, pp. 4178–4186, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. M. Moinpour, K. A. Hayden, J. M. Unger et al., “Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy,” Journal of Clinical Oncology, vol. 26, no. 1, pp. 112–120, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. V. Meng, K. Shinohara, G. D. Grossfeld, and P. R. Carroll, “Local therapy for recurrent prostate cancer,” in Prostate Cancer: Principles and Practice, P. W. Kantoff, P. R. Carroll, and A. V. D’Amico, Eds., pp. 307–316, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2002.
  17. B. J. Trock, M. Han, S. J. Freedland et al., “Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy,” Journal of the American Medical Association, vol. 299, no. 23, pp. 2760–2769, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. R. Choo, G. Hruby, J. Hong et al., “(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 2, pp. 269–276, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Wiegel, G. Lohm, D. Bottke et al., “Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome-results of a retrospective study,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 4, pp. 1009–1016, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. D. Neuhof, T. Hentschel, M. Bischof, G. Sroka-Perez, M. Hohenfellner, and J. Debus, “Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy,” International Journal of Radiation Oncology Biology Physics, vol. 67, no. 5, pp. 1411–1417, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. C. Catton, M. Gospodarowicz, P. Warde et al., “Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate,” Radiotherapy and Oncology, vol. 59, no. 1, pp. 51–60, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. O. K. MacDonald, S. E. Schild, S. Vora et al., “Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?” Urology, vol. 64, no. 4, pp. 760–764, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. S. Katz, M. J. Zelefsky, E. S. Venkatraman, Z. Fuks, A. Hummer, and S. A. Leibel, “Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer,” Journal of Clinical Oncology, vol. 21, no. 3, pp. 483–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. Stephenson, S. F. Shariat, M. J. Zelefsky et al., “Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy,” Journal of the American Medical Association, vol. 291, no. 11, pp. 1325–1332, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. S. Anscher, R. Clough, and R. Dodge, “Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years,” International Journal of Radiation Oncology Biology Physics, vol. 48, no. 2, pp. 369–375, 2000. View at Publisher · View at Google Scholar
  26. J. R. Bernard, S. J. Buskirk, M. G. Heckman et al., “Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 3, pp. 735–740, 2010. View at Publisher · View at Google Scholar · View at PubMed
  27. G. De Meerleer, V. Fonteyne, S. Meersschout et al., “Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy,” Radiotherapy and Oncology, vol. 89, no. 2, pp. 205–213, 2008. View at Publisher · View at Google Scholar · View at PubMed
  28. L. V. Do, T. M. Do, R. Smith, and R. G. Parker, “Postoperative radiotherapy for carcinoma of the prostate: impact on both local control and distant disease-free survival,” American Journal of Clinical Oncology, vol. 25, no. 1, pp. 1–8, 2002. View at Publisher · View at Google Scholar
  29. C. R. King and M. T. Spiotto, “Improved outcomes with higher doses for salvage radiotherapy after prostatectomy,” International Journal of Radiation Oncology Biology Physics, vol. 71, no. 1, pp. 23–27, 2008. View at Publisher · View at Google Scholar · View at PubMed
  30. S. Loeb, K. A. Roehl, D. P. Viprakasit, and W. J. Catalona, “Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy,” European Urology, vol. 54, no. 1, pp. 88–96, 2008. View at Publisher · View at Google Scholar · View at PubMed
  31. J. F. Pazona, M. Han, S. A. Hawkins, K. A. Roehl, and W. J. Catalona, “Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-Year outcome estimates,” Journal of Urology, vol. 174, no. 4, pp. 1282–1286, 2005. View at Publisher · View at Google Scholar
  32. T. M. Pisansky, T. F. Kozelsky, R. P. Myers et al., “Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer,” Journal of Urology, vol. 163, no. 3, pp. 845–850, 2000.
  33. H. G. Van Der Poel, L. Moonen, and S. Horenblas, “Sequential treatment for recurrent localized prostate cancer,” Journal of Surgical Oncology, vol. 97, no. 5, pp. 377–382, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. P. Poortmans, A. Bossi, K. Vandeputte et al., “Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group,” Radiotherapy and Oncology, vol. 84, no. 2, pp. 121–127, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. G. A. Viani, E. J. Stefano, and S. L. Afonso, “Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials,” International Journal of Radiation Oncology Biology Physics, vol. 74, no. 5, pp. 1405–1418, 2009. View at Publisher · View at Google Scholar · View at PubMed
  36. C. R. King and D. S. Kapp, “Radiotherapy after prostatectomy: is the evidence for dose escalation out there?” International Journal of Radiation Oncology Biology Physics, vol. 71, no. 2, pp. 346–350, 2008. View at Publisher · View at Google Scholar · View at PubMed
  37. C. Cozzarini, F. Montorsi, C. Fiorino et al., “Need for high radiation dose (≥70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 4, pp. 966–974, 2009. View at Publisher · View at Google Scholar · View at PubMed
  38. M. Feng, A. L. Hanlon, T. M. Pisansky et al., “Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 5, pp. 1417–1423, 2007. View at Publisher · View at Google Scholar · View at PubMed
  39. G. P. Swanson, M. A. Hussey, C. M. Tangen et al., “Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794,” Journal of Clinical Oncology, vol. 25, no. 16, pp. 2225–2229, 2007. View at Publisher · View at Google Scholar · View at PubMed
  40. M. C. Abramowitz and A. Pollack, “Postprostatectomy radiation therapy for prostate cancer,” Seminars in Radiation Oncology, vol. 18, no. 1, pp. 15–22, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. M. N. Simmons, A. J. Stephenson, and E. A. Klein, “Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy,” European Urology, vol. 51, no. 5, pp. 1175–1184, 2007. View at Publisher · View at Google Scholar · View at PubMed
  42. S. J. Buskirk, T. M. Pisansky, S. E. Schild et al., “Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system,” Journal of Urology, vol. 176, no. 3, pp. 985–990, 2006. View at Publisher · View at Google Scholar · View at PubMed
  43. P. Day, J. Pearce, and D. Dorling, “Twelve worlds: a geo-demographic comparison of global inequalities in mortality,” Journal of Epidemiology and Community Health, vol. 62, no. 11, pp. 1002–1007, 2008. View at Publisher · View at Google Scholar · View at PubMed